- Home
- ATOS vs WBX Comparison
ATOS vs WBX Comparison
Compare ATOS & WBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- WBX
- Stock Information
- Founded
- ATOS 2009
- WBX 2015
- Country
- ATOS United States
- WBX Spain
- Employees
- ATOS N/A
- WBX N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- WBX Industrial Specialties
- Sector
- ATOS Health Care
- WBX Consumer Discretionary
- Exchange
- ATOS Nasdaq
- WBX Nasdaq
- Market Cap
- ATOS 96.8M
- WBX 92.2M
- IPO Year
- ATOS 2012
- WBX N/A
- Fundamental
- Price
- ATOS $0.65
- WBX $0.34
- Analyst Decision
- ATOS Strong Buy
- WBX Buy
- Analyst Count
- ATOS 3
- WBX 3
- Target Price
- ATOS $7.00
- WBX $0.83
- AVG Volume (30 Days)
- ATOS 520.3K
- WBX 431.7K
- Earning Date
- ATOS 03-25-2025
- WBX 05-08-2025
- Dividend Yield
- ATOS N/A
- WBX N/A
- EPS Growth
- ATOS N/A
- WBX N/A
- EPS
- ATOS N/A
- WBX N/A
- Revenue
- ATOS N/A
- WBX $169,730,821.00
- Revenue This Year
- ATOS N/A
- WBX $0.51
- Revenue Next Year
- ATOS N/A
- WBX $38.01
- P/E Ratio
- ATOS N/A
- WBX N/A
- Revenue Growth
- ATOS N/A
- WBX 14.03
- 52 Week Low
- ATOS $0.65
- WBX $0.29
- 52 Week High
- ATOS $2.31
- WBX $1.73
- Technical
- Relative Strength Index (RSI)
- ATOS 31.82
- WBX 39.61
- Support Level
- ATOS $0.66
- WBX $0.29
- Resistance Level
- ATOS $0.71
- WBX $0.36
- Average True Range (ATR)
- ATOS 0.04
- WBX 0.03
- MACD
- ATOS -0.00
- WBX 0.00
- Stochastic Oscillator
- ATOS 0.00
- WBX 45.45
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates smart charging system combining technology design that manages the communication between user, vehicle, grid, building, and charger. The company is engaged in designing, manufacturing, and distributing faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA) which is also its key revenue generating segment, North America, and Asia‑Pacific.